Page last updated: 2024-09-04

levofloxacin and Legionellosis

levofloxacin has been researched along with Legionellosis in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (25.00)29.6817
2010's8 (66.67)24.3611
2020's1 (8.33)2.80

Authors

AuthorsStudies
Chen, Q; Fan, X; Guo, YL; Li, Q; Lv, XT; Zhao, C1
Beraud, L; Descours, G; Ginevra, C; Ibranosyan, M; Jarraud, S; Lemaire, H; Ranc, AG1
Barker, L; Blosser, SJ; May, M; Raposo, H; Relich, RF; Schmitt, BH1
Atic, A; Basic-Jukic, N; Kirincich, J; Sakic, Z1
Kolditz, M; Lück, C1
Argemi, X; Hansmann, Y; Keller, N; Martin, A; Martin, M; Martin, T; Twizeyimana, E1
Bobyleva, ZD; Leshchenko, IV1
Baltch, AL; Bopp, LH; Michelsen, PB; Ritz, WJ; Smith, RP1
Fukuta, Y; Veldkamp, PJ; William Pasculle, A; Yildiz-Aktas, IZ1
Levi, MH; Mahadevi, P; Merav, AD; Nana, M; Patel, MC; Robbins, N1
Lück, PC; Steinert, M1
Adrián, F; del Campo, R; García, C; Gómez-Lus, P; Gómez-Lus, R; Rubio, MC; Sánchez, S1

Reviews

5 review(s) available for levofloxacin and Legionellosis

ArticleYear
Legionella micdadei Aquaticum Infection: a Case Report and Literature Review.
    Clinical laboratory, 2022, Apr-01, Volume: 68, Issue:4

    Topics: Adult; Azithromycin; Erythromycin; Female; Humans; Legionella; Legionellaceae; Legionellosis; Levofloxacin; Male; Middle Aged; Pneumonia

2022
The clinical presentation of Legionella arthritis reveals the mode of infection and the bacterial species: case report and literature review.
    BMC infectious diseases, 2019, Oct-21, Volume: 19, Issue:1

    Topics: Accidental Falls; Administration, Oral; Adrenal Cortex Hormones; Arthritis, Infectious; Female; Humans; Hydrocarbons; Immunocompromised Host; Injections, Intra-Articular; Legionellaceae; Legionellosis; Levofloxacin; Middle Aged; Polymerase Chain Reaction; Rifampin; RNA, Ribosomal, 16S; Treatment Outcome

2019
Legionella micdadei prosthetic valve endocarditis complicated by brain abscess: case report and review of the literature.
    Scandinavian journal of infectious diseases, 2012, Volume: 44, Issue:6

    Topics: Adult; Aged; Anti-Bacterial Agents; Bacteriological Techniques; Brain; Brain Abscess; Echocardiography; Endocarditis, Bacterial; Endocardium; Female; Humans; Legionella; Legionellosis; Levofloxacin; Magnetic Resonance Imaging; Male; Middle Aged; Ofloxacin; Prosthesis-Related Infections; Radiography

2012
L. micdadei PVE successfully treated with levofloxacin/valve replacement: case report and review of the literature.
    The Journal of infection, 2005, Volume: 51, Issue:5

    Topics: Anti-Bacterial Agents; Bioprosthesis; Device Removal; Endocarditis, Bacterial; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Hodgkin Disease; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Legionella; Legionellosis; Levofloxacin; Male; Middle Aged; Ofloxacin; Prosthesis-Related Infections; Radiation Injuries; Reoperation; Treatment Outcome

2005
[Pathogenesis, diagnosis and therapy of Legionella infections].
    Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz, 2006, Volume: 49, Issue:5

    Topics: Anti-Bacterial Agents; Antibodies, Bacterial; Antigens, Bacterial; Aza Compounds; Azithromycin; Ciprofloxacin; Diagnosis, Differential; DNA, Bacterial; Fluoroquinolones; Humans; Incidence; Legionella; Legionella pneumophila; Legionellosis; Legionnaires' Disease; Levofloxacin; Moxifloxacin; Ofloxacin; Polymerase Chain Reaction; Quinolines; Serotyping; Virulence

2006

Other Studies

7 other study(ies) available for levofloxacin and Legionellosis

ArticleYear
Legionella indianapolisensis sp. nov., isolated from a patient with pulmonary abscess.
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2018, Volume: 69

    Topics: Aged; Anti-Bacterial Agents; Bronchoalveolar Lavage; Bronchoalveolar Lavage Fluid; DNA, Bacterial; Humans; Indiana; Legionella; Legionellosis; Levofloxacin; Lung Abscess; Male; Mass Spectrometry; Phylogeny; RNA, Ribosomal, 16S; Treatment Outcome

2018
Community Acquired Legionnaire's Disease in a Kidney Transplant Patient.
    Prilozi (Makedonska akademija na naukite i umetnostite. Oddelenie za medicinski nauki), 2018, Dec-01, Volume: 39, Issue:2-3

    Topics: Anti-Bacterial Agents; Community-Acquired Infections; Critical Care; Humans; Immunocompromised Host; Kidney Transplantation; Legionellosis; Legionnaires' Disease; Levofloxacin; Male; Middle Aged; Piperacillin, Tazobactam Drug Combination; Pneumonia; Radiography, Thoracic; Treatment Outcome

2018
[Legionella and Legionellosis].
    Deutsche medizinische Wochenschrift (1946), 2019, Volume: 144, Issue:15

    Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Humans; Legionella; Legionellosis; Levofloxacin

2019
A non-fatal pneumonia due to Legionella longbeachae in a patient with systemic lupus erythematosus.
    Lupus, 2016, Volume: 25, Issue:13

    Topics: Adult; Female; Humans; Legionella longbeachae; Legionellosis; Levofloxacin; Lupus Erythematosus, Systemic; Pneumonia; Spiramycin; Treatment Outcome

2016
[Clinical features and delayed aftereffects of Legionellosis pneumonia during an epidemic outbreak].
    Klinicheskaia meditsina, 2010, Volume: 88, Issue:4

    Topics: Anti-Bacterial Agents; Azithromycin; Disease Outbreaks; Female; Humans; Legionellosis; Levofloxacin; Male; Middle Aged; Ofloxacin; Pneumonia, Bacterial; Russia; Treatment Outcome; Water Supply

2010
Activities of tigecycline and comparators against Legionella pneumophila and Legionella micdadei extracellularly and in human monocyte-derived macrophages.
    Diagnostic microbiology and infectious disease, 2011, Volume: 69, Issue:1

    Topics: Anti-Bacterial Agents; Bacterial Load; Bacterial Typing Techniques; Erythromycin; Humans; Legionella; Legionellosis; Levofloxacin; Macrophages; Microbial Sensitivity Tests; Microbial Viability; Minocycline; Ofloxacin; Serotyping; Tigecycline; Time Factors

2011
Comparative in vitro bacteriostatic and bactericidal activity of trovafloxacin, levofloxacin and moxifloxacin against clinical and environmental isolates of Legionella spp.
    International journal of antimicrobial agents, 2001, Volume: 18, Issue:1

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Fluoroquinolones; Humans; Legionella; Legionellosis; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Naphthyridines; Ofloxacin; Quinolines; Rifampin

2001